pyridostigmine bromide has been researched along with Pituitary Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersen, M; Fisker, S; Ørskov, H | 1 |
Falhof, J; Hoeck, HC; Jakobsen, PE; Laurberg, P; Vestergaard, P | 1 |
Andersen, M; Hagen, C; Jensen, CH; Larsen, JB; Schrøder, HD; Støving, RK; Teisner, B | 1 |
1 review(s) available for pyridostigmine bromide and Pituitary Diseases
Article | Year |
---|---|
Diagnosis of growth hormone deficiency.
Topics: Adult; Arginine; Growth Disorders; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Immunoassay; Insulin; Oligopeptides; Pituitary Diseases; Pyridostigmine Bromide | 2005 |
1 trial(s) available for pyridostigmine bromide and Pituitary Diseases
Article | Year |
---|---|
Fetal antigen 1 in healthy adults and patients with pituitary disease: relation to physiological, pathological, and pharmacological GH levels.
Topics: Acromegaly; Adult; Circadian Rhythm; Enzyme-Linked Immunosorbent Assay; Female; Glycoproteins; Gonadotropin-Releasing Hormone; Hormones; Human Growth Hormone; Humans; Immunohistochemistry; Octreotide; Pituitary Diseases; Pyridostigmine Bromide; Reference Values | 2001 |
1 other study(ies) available for pyridostigmine bromide and Pituitary Diseases
Article | Year |
---|---|
Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues.
Topics: Adult; Clonidine; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypoglycemia; Hypothalamic Diseases; Insulin; Insulin-Like Growth Factor I; Male; Middle Aged; Pituitary Diseases; Pyridostigmine Bromide; Reproducibility of Results | 2000 |